Related Experiment Videos

Targeted modulation of MGMT: clinical implications

Lili Liu1, Stanton L Gerson

  • 1Department of Medicine, Division of Hematology/Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA..

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 24, 2006
PubMed

Insights

O(6)-Methylguanine DNA methyltransferase (MGMT) repairs DNA damage from alkylating agents, influencing mutagenicity and chemotherapy resistance. Understanding MGMT

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • O(6)-Methylguanine DNA methyltransferase (MGMT) is a DNA repair enzyme.
  • MGMT repairs DNA damage caused by alkylating agents, including therapeutic drugs and carcinogens.
  • O(6)-alkylguanine is a DNA lesion that can lead to mutations and cytotoxicity.

Purpose of the Study:

  • To summarize the clinical significance of MGMT expression.
  • To review the targeted modulation of MGMT in clinical settings.
  • To highlight MGMT's role in cancer etiology and treatment resistance.

Main Methods:

  • Literature review of studies on MGMT.
  • Analysis of clinical data related to MGMT expression levels.
  • Evaluation of therapeutic strategies targeting MGMT.

Main Results:

  • MGMT expression levels correlate with patient response to certain chemotherapies.
  • Targeted inhibition or modulation of MGMT can enhance the efficacy of alkylating agents.
  • MGMT plays a critical role in determining the mutagenic and cytotoxic effects of DNA alkylation.

Conclusions:

  • MGMT is a key determinant of sensitivity and resistance to alkylating chemotherapies.
  • Modulating MGMT activity represents a promising strategy for improving cancer treatment outcomes.
  • Further research into MGMT's clinical implications is warranted.

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...